Page last updated: 2024-10-23

seratrodast and Pulmonary Disease, Chronic Obstructive

seratrodast has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.

Research Excerpts

ExcerptRelevanceReference
"COPD (Chronic Obstructive Pulmonary Disease) and bronchial asthma are two severe lung diseases which represent a major problem of world public health."2.43Prostanoids as pharmacological targets in COPD and asthma. ( Dogné, JM; Masereel, B; Rolin, S, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rolin, S1
Masereel, B1
Dogné, JM1

Reviews

1 review available for seratrodast and Pulmonary Disease, Chronic Obstructive

ArticleYear
Prostanoids as pharmacological targets in COPD and asthma.
    European journal of pharmacology, 2006, Mar-08, Volume: 533, Issue:1-3

    Topics: Animals; Asthma; Benzoquinones; Carbazoles; Enzyme Inhibitors; F2-Isoprostanes; Heptanoic Acids; Hum

2006